Rybelsus® reduces cardiovascular events in adults with type 2 diabetes and cardiovascular or chronic kidney disease 4th April 2025
Teenager becomes first person in the UK to receive groundbreaking diabetes treatment 13th February 2025
Type 1 diabetes and chronic kidney disease can be treated with sotagliflozin, study indicates 27th January 2025
Cardiovascular benefits of semaglutide maintained in people with impaired kidney function 13th September 2024
